Latest Medical Research Council Stories
LONDON, February 4 /PRNewswire/ -- A major centre created by the Medical Research Council (MRC) and MRC Technology (MRCT) in order to fast-track the discovery and development of novel drugs, opens its first call for targets today. The MRCT Centre for Therapeutics Discovery (CTD), based in London, is seeking small molecule drug discovery and therapeutic antibody targets from academic researchers. The CTD would like to collaborate with scientists in all universities to develop drug...
Scientists have discovered five genetic variants that are associated with the health of the human lung.
Sir Peter Mansfield, The University of Nottinghamâ€™s Nobel Laureate for Physiology and Medicine, is to be recognized, once again, for his part in one of the most important breakthroughs in medical science.
Medical Research Council (MRC) scientists have made an important advance in understanding the biological processes involved when cells are prompted to die. The work may help scientists to eventually develop new treatments for the many common diseases and conditions which occur when cell death goes wrong.
Recent stem cell advances and Sir Philip Cohen's groundbreaking research into new drug targets showcase Scotland's life sciences innovation at BIO 2009 ATLANTA, May 18 /PRNewswire/ -- At this year's BIO International Convention, May 18-21 in Atlanta, Scotland will showcase the commercial success of its research collaborations with global pharmaceutical and biotech companies, as well as major scientific advancements in stem cells, drug discovery, translational medicine, medical technology...
A new report has linked the use of chemicals found in food, cosmetics and cleaning products to an increased risk of birth defects, testicular cancer and infertility among unborn boys.
Carboplatin, which is often used to treat ovarian and lung cancer, can replace radiotherapy to cure early-stage seminoma, a Medical Research Council study has found.The drug is being hailed as a "safer cure" for the cancer by experts, with fewer long-term risks.About 40 to 45 per cent of testicular cancers are early-stage seminoma and between 780 and 880 men are diagnosed with this stage of the disease each year in the UK.In the early stages the cancer is either confined to the testicle or...
LEXINGTON, Mass., Aug. 22 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc.
By Park, Joo Hun; Kim, Dong Soon; Park, I-Nae; Jan
A British research body said on Wednesday said it planned to launch a 10 million pound ($17 million) fund to further the study of deadly bird flu.